Taking together, our study expands the IDUA mutation spectrum and contributes to the recognition and accurate diagnosis of its impact on phenotypic expression in MPS I patients, which was previously misdiagnosed as congenital heart disease for almost a decade. This evidence concerns the gene IDUA and Scheie syndrome.